 Home > Encyclopedia > Chartreusin

Chartreusin

Chartreusin structure

CAS No:
6377-18-0
Formula:
C32H32O14
Chemical Name:
Chartreusin
Synonyms:
Benzo[h][1]benzopyrano[5,4,3-cde][1]benzopyran-5,12-dione,10-[[6-deoxy-2-O-(6-deoxy-3-O-methyl-α-D-galactopyranosyl)-β-D-galactopyranosyl]oxy]-6-hydroxy-1-methyl-;Chartreusin;10-[[6-Deoxy-2-O-(6-deoxy-3-O-methyl-α-D-galactopyranosyl)-β-D-galactopyranosyl]oxy]-6-hydroxy-1-methylbenzo[h][1]benzopyrano[5,4,3-cde][1]benzopyran-5,12-dione;NSC 5159;Antibiotic X 465A;Lambdamycin;1393-73-3;1393-74-4;1403-35-6;59979-62-3
Categories:
Biochemical Engineering > Saccharides

Request for Quotation

Description

Chartreusin is a glycoside and a benzochromenone.

Chartreusin Basic Attributes

Molecular Weight：

640.594

Exact Mass：

640.59

UNII：

HS0H395E3O

Characteristics

PSA：

200

XLogP3：

1.36980

Density：

1.63g/cm3

Melting Point：

185 °C

Boiling Point：

945.5ºC at 760 mmHg

Flash Point：

307.8ºC

Refractive Index：

1.718

Water Solubility：

15mg/L(25 ºC)

Safety Information

safety instructions：

22-36/37/39-45

Marks：

Precautionary statement(s)：

P201, P202, P281, P308+P313, P405, P501

Hazard Statements：

H351

GHS Classification：

|Warning|H351 (100%): Suspected of causing cancer [Warning Carcinogenicity]|P201, P202, P281, P308+P313, P405, and P501|Aggregated GHS information provided by 127 companies from 1 notifications to the ECHA C&L Inventory.

Drug Information

MeSH：

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)

MeSH Entry Terms：

chartreusin

Chartreusin Use and Manufacturing

Chartreusin is an antitumour antibiotic that binds to GC-rich tracts in DNA, with a clear preference for B-DNA over Z-DNA. It inhibits RNA synthesis and causes single-strand scission of DNA via the formation of free radicals. Chartreusin is also a potent inhibitor of topoisomerase II. Chartreusin is an antitumor antibiotic that binds to GC-rich tracts in DNA, with a clear preference for B-DNA over Z-DNA. It inhibits RNA synthesis and causes single-strand scission of DNA via the formation of free radicals. Chartreusin is also a potent inhibitor of topoisomerase II.

Computed Properties

Molecular Weight:640.6
XLogP3:2.1
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:14
Rotatable Bond Count:5
Exact Mass:640.17920569
Monoisotopic Mass:640.17920569
Topological Polar Surface Area:200
Heavy Atom Count:46
Complexity:1150
Defined Atom Stereocenter Count:10
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Learn More Other Chemicals

5'-deoxy-5'-thioinosine 5'-monophosphate

21959-63-7
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone

22003-30-1
5'-azacytidine5'-monophosphate

2226-72-4
Decarboxylated AdoMet Formula

22365-13-5
2′-Deoxy-6-thioinosine Formula

2239-64-7
2,2'-Anhydro-5-methyluridine Formula

22423-26-3
Quercetin 3-glucuronide Structure

22688-79-5
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)pyrimidin-2-one Structure

22882-02-6
What is Sucrose

57-50-1
What is C18Dihydroceramide

2304-80-5

Hot Searches: dipotassium phosphate; trisodium citrate; lead sulfate; chloric acid formula; ammonium phosphate formula; potassium hydrogen phthalate

Guide of Chartreusin

Description
Basic Attributes
Characteristics
Safety Information
Drug Information
Use and Manufacturing
Computed Properties
Learn More Other Chemicals

Chartreusin

SDS

Request for Quotation



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.